Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.72M Buy
28,536
+2,045
+8% +$196K 0.33% 84
2026
Q1
$2.75M Buy
26,491
+1,150
+5% +$130K 0.39% 73
2025
Q4
$2.56M Buy
25,341
+2,583
+11% +$280K 0.37% 75
2025
Q3
$2.81M Buy
22,758
+843
+4% +$105K 0.42% 67
2025
Q2
$2.63M Buy
+21,915
New +$2.92M 0.43% 62
2023
Q1
Sell
-65
Closed -$9.06K 163
2022
Q4
$9.06K Buy
65
+1
+2% +$142 ﹤0.01% 330
2022
Q3
$8K Buy
64
+1
+2% +$144 ﹤0.01% 314
2022
Q2
$9K Hold
63
﹤0.01% 291
2022
Q1
$9K Hold
63
﹤0.01% 286
2021
Q4
$11K Buy
63
+1
+2% +$167 ﹤0.01% 283
2021
Q3
$10K Hold
62
﹤0.01% 277
2021
Q2
$11K Sell
62
-401
-87% -$73.2K ﹤0.01% 271
2021
Q1
$89K Buy
463
+163
+54% +$31.4K 0.03% 178
2020
Q4
$61K Sell
300
-159
-35% -$32.9K 0.02% 188
2020
Q3
$96K Buy
459
+1
+0.2% +$223 0.03% 164
2020
Q2
$100K Sell
458
-11,100
-96% -$2.22M 0.04% 158
2020
Q1
$2M Buy
11,558
+936
+9% +$155K 1.07% 18
2019
Q4
$1.63K Buy
+10,622
New +$1.59M 0.79% 29

Other funds holding CLX

Leelyn Smith's CLX Position: Q2 2026 in Review

Leelyn Smith increased its Clorox (CLX) stake by 7.7% in Q2 2026, buying an estimated $196K and bringing the position to 28,536 shares worth $2.72M. The position accounts for 0.33% of the portfolio, ranked #84.

Leelyn Smith first reported a position in CLX in Q4 2019 and has held it in 18 quarters since. The position peaked at $2.81M in Q3 2025. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Leelyn Smith held 28,536 shares of Clorox worth $2.72M as of Q2 2026.
  • Leelyn Smith bought 2,045 Clorox shares in Q2 2026, an estimated $196K.
  • Clorox made up 0.33% of Leelyn Smith's portfolio in Q2 2026, its #84 holding.
  • Leelyn Smith first reported a position in Clorox in Q4 2019 and has held it in 18 quarters since.
  • Leelyn Smith's Clorox position peaked at $2.81M in Q3 2025.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Leelyn Smith's 13F filing for Q2 2026, filed 24 Jul 2026.